• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Regulatory Information

  • Print
  • Share
  • E-mail

V. Decision to Further Delay the Effective Date

Prescription Drug Marketing Act Report to Congress (2001): Back to Table of Contents

Previous Section: Agency Conclusions

The Agency has delayed the effectiveness date for §§ 203.3(u) and 203.50 and the applicability of § 203.3(q) to wholesale distribution of blood derivatives by health care entities until April 1, 2002.

Next Section: Attachment A: List of Presenters at the Hearing